Yuste, E.; Ruiz-De-León, M.J.; Casado, J.L.; Moreno, A.; Vivancos, M.J.; Pérez-ElÃas, M.J.; Dronda, F.; Quereda, C.; Sánchez-Merino, V.; Vallejo, A.
Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution. Vaccines 2025, 13, 639.
https://doi.org/10.3390/vaccines13060639
AMA Style
Yuste E, Ruiz-De-León MJ, Casado JL, Moreno A, Vivancos MJ, Pérez-ElÃas MJ, Dronda F, Quereda C, Sánchez-Merino V, Vallejo A.
Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution. Vaccines. 2025; 13(6):639.
https://doi.org/10.3390/vaccines13060639
Chicago/Turabian Style
Yuste, Eloisa, MarÃa J. Ruiz-De-León, José L. Casado, Ana Moreno, MarÃa J. Vivancos, MarÃa J. Pérez-ElÃas, Fernando Dronda, Carmen Quereda, VÃctor Sánchez-Merino, and Alejandro Vallejo.
2025. "Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution" Vaccines 13, no. 6: 639.
https://doi.org/10.3390/vaccines13060639
APA Style
Yuste, E., Ruiz-De-León, M. J., Casado, J. L., Moreno, A., Vivancos, M. J., Pérez-ElÃas, M. J., Dronda, F., Quereda, C., Sánchez-Merino, V., & Vallejo, A.
(2025). Enhanced HIV-1 Neutralizing Antibody Breadth in HTLV-2 Co-Infected Individuals: Influence of Antiretroviral Regimen and B Cell Subset Distribution. Vaccines, 13(6), 639.
https://doi.org/10.3390/vaccines13060639
